欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/0751/003
药品名称LOVENOX 6.000 IE (60 mg)/0,6 ml
活性成分
    • Enoxaparin sodium 100.0 mg/ml
剂型Solution for injection in prefilled syringe
上市许可持有人sanofi-aventis GmbH Saturn Tower, Leonard-Bernstein-Straße 10 A-1220 Vienna
参考成员国 - 产品名称Austria (AT)
LOVENOX 6.000 IE (60 mg)/0,6 ml Injektionslösung in einer Fertigspritze
互认成员国 - 产品名称
    • Germany (DE)
    • Belgium (BE)
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Poland (PL)
    • Latvia (LV)
    • Estonia (EE)
      CLEXANE
    • Hungary (HU)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Malta (MT)
    • Croatia (HR)
许可日期2017/03/20
最近更新日期2025/09/03
药物ATC编码
    • B01AB05 enoxaparin
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase